SOLID DISPERSIONS, CONTAINING KINASE INHIBITORS

摘要

FIELD: medicine.SUBSTANCE: invention represents product in form of solid dispersion, containing N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N'-(3-fluorophenyl)urea or its pharmaceutically acceptable salt, at least, one pharmaceutically acceptable water-soluble polymer carrier and, at least, one pharmaceutically acceptable surface-active substance.EFFECT: solid dispersion is suitable for peroral introduction to requiring it subject for cancer treatment.24 cl, 4 ex, 2 tbl